D35.2: Benign neoplasm of pituitary gland
D35.2, benign neoplasm of pituitary gland, is listed as a covered diagnosis in 9 Medicare billing and coding articles that apply to 45 HCPCS Level II codes, including J1071 (Injection, testosterone cypionate, 1 mg), J3145 (Injection, testosterone undecanoate, 1 mg), J3490 (Unclassified drugs). 4 of these codes have a 2026 DMEPOS fee schedule amount; E0783 pays $9,917.33 to $11,667.45 (NU) depending on the state. The articles come from 5 Medicare contractors. A listed diagnosis supports medical necessity only; coverage still depends on the LCD's criteria and on documentation in the medical record.
HCPCS Level II codes with D35.2 as a covered diagnosis
| Code | Description | Medicare coverage | DMEPOS fee 2026 (state range) | Articles listing it |
|---|---|---|---|---|
| J1071 | Injection, testosterone cypionate, 1 mg | Special coverage instructions apply | — | 2 |
| J3145 | Injection, testosterone undecanoate, 1 mg | Special coverage instructions apply | — | 2 |
| J3490 | Unclassified drugs | Special coverage instructions apply | — | 2 |
| J3121 | Injection, testosterone enanthate, 1 mg | Special coverage instructions apply | — | 2 |
| J1072 | Injection, testosterone cypionate (azmiro), 1 mg | Special coverage instructions apply | — | 1 |
| G0340 | Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatment | Carrier judgment | — | 2 |
| G0339 | Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment | Carrier judgment | — | 2 |
| G0563 | Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions | Carrier judgment | — | 1 |
| C8900 | Magnetic resonance angiography with contrast, abdomen | Special coverage instructions apply | — | 2 |
| C8901 | Magnetic resonance angiography without contrast, abdomen | Special coverage instructions apply | — | 2 |
| C8902 | Magnetic resonance angiography without contrast followed by with contrast, abdomen | Special coverage instructions apply | — | 2 |
| C8909 | Magnetic resonance angiography with contrast, chest (excluding myocardium) | Special coverage instructions apply | — | 2 |
| C8910 | Magnetic resonance angiography without contrast, chest (excluding myocardium) | Special coverage instructions apply | — | 2 |
| C8911 | Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium) | Special coverage instructions apply | — | 2 |
| C8912 | Magnetic resonance angiography with contrast, lower extremity | Special coverage instructions apply | — | 2 |
| C8913 | Magnetic resonance angiography without contrast, lower extremity | Special coverage instructions apply | — | 2 |
| C8914 | Magnetic resonance angiography without contrast followed by with contrast, lower extremity | Special coverage instructions apply | — | 2 |
| C8918 | Magnetic resonance angiography with contrast, pelvis | Special coverage instructions apply | — | 2 |
| C8919 | Magnetic resonance angiography without contrast, pelvis | Special coverage instructions apply | — | 2 |
| C8920 | Magnetic resonance angiography without contrast followed by with contrast, pelvis | Special coverage instructions apply | — | 2 |
| C8931 | Magnetic resonance angiography with contrast, spinal canal and contents | Special coverage instructions apply | — | 1 |
| C8932 | Magnetic resonance angiography without contrast, spinal canal and contents | Special coverage instructions apply | — | 1 |
| C8933 | Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents | Special coverage instructions apply | — | 1 |
| C8934 | Magnetic resonance angiography with contrast, upper extremity | Special coverage instructions apply | — | 1 |
| C8935 | Magnetic resonance angiography without contrast, upper extremity | Special coverage instructions apply | — | 1 |
20 more codes are listed. See every code with payment by region in Caduvo.
Medicare policy articles listing D35.2
- A57615: Billing and Coding: Treatment of Males with Low Testosterone (Noridian Healthcare Solutions, LLC (MAC - Part A, MAC - Part B); 4 Level II codes). LCD with the same title: L36538, L39086
- A58828: Billing and Coding: Treatment of Males with Low Testosterone (Palmetto GBA (MAC - Part A, MAC - Part B); 5 Level II codes). LCD with the same title: L36538, L39086
- A56874: Billing and Coding: Stereotactic Radiation Therapy: Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) (Wellpoint Federal (MAC - Part A, MAC - Part B); 3 Level II codes). LCD with the same title: L35076
- A59350: Billing and Coding: Radiation Therapies (Palmetto GBA (MAC - Part A, MAC - Part B); 2 Level II codes). LCD with the same title: L39553
- A56805: Billing and Coding: Magnetic Resonance Angiography (MRA) (Novitas Solutions, Inc. (MAC - Part A, MAC - Part B); 12 Level II codes). LCD with the same title: L33633, L34372, L34865
- A56747: Billing and Coding: Magnetic Resonance Angiography (MRA) (Wellpoint Federal (MAC - Part A, MAC - Part B); 18 Level II codes). LCD with the same title: L33633, L34372, L34865
- A57056: Billing and Coding: Aortography and Peripheral Angiography (First Coast Service Options, Inc. (MAC - Part A, MAC - Part B); 1 Level II codes). LCD with the same title: L36767
- A56695: Billing and Coding: Implantable Infusion Pump (Palmetto GBA (MAC - Part B); 9 Level II codes). LCD with the same title: L33461
- A56612: Billing and Coding: CT of the Head (Palmetto GBA (MAC - Part A, MAC - Part B); 9 Level II codes). LCD with the same title: L34417
A diagnosis listed as covered in a billing and coding article supports medical necessity for the article's codes; it does not guarantee payment. Coverage depends on the LCD's criteria, the contractor's jurisdiction and documentation in the medical record.
Other D35 diagnoses (Benign neoplasm of other and unspecified endocrine glands)
- D35.3 — Benign neoplasm of craniopharyngeal duct
- D35.4 — Benign neoplasm of pineal gland
- D35.5 — Benign neoplasm of carotid body
- D35.6 — Benign neoplasm of aortic body and other paraganglia
Frequently asked questions
Does Medicare cover D35.2 (Benign neoplasm of pituitary gland)?
Medicare covers items and services, not diagnoses. 9 Medicare billing and coding articles list D35.2 as a covered diagnosis for 45 HCPCS Level II codes: the diagnosis can support medical necessity for those codes, but payment still depends on the LCD's coverage criteria and the medical record.
Which HCPCS codes can be billed with ICD-10 D35.2?
The Level II codes from the policies most specific to this diagnosis are J1071 (Injection, testosterone cypionate, 1 mg, 2 articles); J3145 (Injection, testosterone undecanoate, 1 mg, 2 articles); J3490 (Unclassified drugs, 2 articles); J3121 (Injection, testosterone enanthate, 1 mg, 2 articles); J1072 (Injection, testosterone cypionate (azmiro), 1 mg, 1 article). Code choice depends on the item supplied; check each code's descriptor.
What does Medicare pay for equipment billed with D35.2?
Under the 2026 DMEPOS fee schedule (non-rural state fees): E0783 $9,917.33 to $11,667.45 (NU); E0786 $10,969.75 to $11,380.88 (NU); E0782 $5,200.92 to $6,118.73 (NU); E0785 $572.38 to $673.39 (KF). Medicare pays 80% of the allowed amount after the Part B deductible.
Which Medicare policy articles list D35.2?
A57615 (Billing and Coding: Treatment of Males with Low Testosterone); A58828 (Billing and Coding: Treatment of Males with Low Testosterone); A56874 (Billing and Coding: Stereotactic Radiation Therapy: Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT)), and 6 more articles.
What is ICD-10-CM code D35.2?
D35.2 is the ICD-10-CM code for benign neoplasm of pituitary gland, in category D35 (Benign neoplasm of other and unspecified endocrine glands), chapter 2: Neoplasms.
Next steps
- Run a reimbursement report for a device billed under J1071
- Watch J1071 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1071
Sources: CMS Medicare Coverage Database billing and coding articles (covered ICD-10 code lists and HCPCS links); ICD-10-CM FY2026; CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule 2026 (non-rural state fees). Not billing or legal advice.